Dr. Abrams' research involves the investigation of risk factors for progression in patients with Barrett's esophagus and esophageal cancer. Prior to his faculty appointment here at Columbia, Dr. Abrams received further training in cancer epidemiology through a post-doctoral fellowship as part of the NCI-funded Training Program in Cancer-Related Population Sciences.
Dr. Abrams received a K07 career development award from the National Cancer Institute to study risk factors for site-specific metastasis in esophageal cancer. The major areas of Dr. Abrams' research relate to the epidemiology of Barrett's esophagus and esophageal cancer, biomarker studies of risk of progression, and prevention of esophageal cancer. Dr. Abrams also works closely with Dr. Charles Lightdale on clinical trials using novel endoscopic techniques for the treatment of dysplasia and early cancer in patients with Barrett's esophagus. They are also involved in clinical trials of the prevention of esophageal cancer.